Hasil Pencarian (2)
small molecule | CAS: 214766-78-6
Degarelix is used for the treatment of advanced prostate cancer. Degarelix is a synthetic peptide derivative drug which binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocks interaction with GnRH. This antagonism reduces l…
Kategori:
Amino Acids, Peptides, and ProteinsAntineoplastic AgentsAntineoplastic and Immunomodulating Agents
+9
Target Protein:
Gonadotropin-releasing hormone receptor
Waktu ParuhTerminal half-life:…
Vol. DistribusiCentral compartment…
KlirensFollowing subcutane…
Genetik
-
small molecule | CAS: 737789-87-6
Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of several hormone-responsive conditions. It was first approved in Japan in 2019, under the brand name Relumina, for the symptomatic treatment of uterine fibroids,[…
Kategori:
AmidesAnti-Gonadotropin-Releasing HormonesAntiandrogens
+30
Target Protein:
Gonadotropin-releasing hormone receptor
Waktu ParuhThe average effecti…
Vol. Distribusi-
KlirensThe average renal c…
Genetik
-